医学
米氮平
抗抑郁药
重症监护医学
萧条(经济学)
梅德林
精神科
政治学
宏观经济学
经济
法学
焦虑
作者
Anthony J. Cleare,Roman Dunčko
出处
期刊:Medicine
[Elsevier]
日期:2016-12-01
卷期号:44 (12): 756-760
被引量:1
标识
DOI:10.1016/j.mpmed.2016.09.004
摘要
This article outlines current guidelines for the pharmacological treatment of depression. For acute treatment of moderate to severe depression in the absence of specific factors, the recommendation is treatment with a selective serotonin reuptake inhibitor or mirtazapine. Other options for acute antidepressant treatment are discussed, and advantages and disadvantages of specific drugs are outlined. Recommendations for next-step treatment for patients with an inadequate response include increasing the dose, switching to another antidepressant, augmentation with another agent or using a combination of antidepressants. Again, recommendations for specific drugs are outlined, and the common advantages and disadvantages of specific drugs are listed in a table format. The options for non-pharmacological treatments are briefly explored in regards to symptom severity and other clinical features, and a list of non-pharmacological treatment options is provided.
科研通智能强力驱动
Strongly Powered by AbleSci AI